VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.8900
-0.0504 (-5.36%)
At close: Jun 20, 2025, 4:00 PM
0.9016
+0.0116 (1.30%)
After-hours: Jun 20, 2025, 6:14 PM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $14.83 million as of June 20, 2025. Its market cap has decreased by -57.64% in one year.
Market Cap
14.83M
Enterprise Value
-35.38M
1-Year Change
-57.64%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $14.83M, a decrease of -93.54%. That is a compound annual growth rate of -40.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 14.83M | -69.99% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | 265.25M | 15.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.47B |
| Johnson & Johnson | 364.38B |
| Novo Nordisk | 331.06B |
| AbbVie | 329.82B |
| UnitedHealth Group | 281.35B |
| Abbott Laboratories | 231.40B |
| Novartis AG | 229.92B |
| AstraZeneca | 223.18B |